Raymond James & Associates’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,416	Closed	-$4K	–	3635
2018 Q4	$4K	Hold	1,416	–	–	﹤0.01%	3494
2018 Q3	$10K	Sell	1,416 -3	-0.2%	-$21	﹤0.01%	3579
2018 Q2	$11K	Sell	1,419 -179	-11%	-$2.39K	﹤0.01%	3521
2018 Q1	$56K	Hold	1,598	–	–	﹤0.01%	3311
2017 Q4	$68K	Buy	1,598 +185	+13%	+$7.92K	﹤0.01%	3255
2017 Q3	$61K	Sell	1,413 -9	-0.6%	-$337	﹤0.01%	3225
2017 Q2	$53K	Buy	1,422 +637	+81%	+$28.2K	﹤0.01%	3179
2017 Q1	$43K	Buy	785 +53	+7%	+$2.76K	﹤0.01%	3154
2016 Q4	$39K	Sell	732 -33	-4%	-$1.88K	﹤0.01%	3105
2016 Q3	$46K	Buy	+765	New	+$47.6K	﹤0.01%	3086
2015 Q3	–	Sell	-775	Closed	-$293K	–	2283
2015 Q2	$293K	Sell	775 -130	-14%	-$51.6K	﹤0.01%	2289
2015 Q1	$378K	Buy	+905	New	+$324K	﹤0.01%	2144